Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and ...

New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...

New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...